126 related articles for article (PubMed ID: 12153156)
1. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis.
Schmitt A; Drouin A; Massé JM; Guichard J; Shagraoui H; Cramer EM
Leuk Lymphoma; 2002 Apr; 43(4):719-24. PubMed ID: 12153156
[TBL] [Abstract][Full Text] [Related]
2. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.
Schmitt A; Jouault H; Guichard J; Wendling F; Drouin A; Cramer EM
Blood; 2000 Aug; 96(4):1342-7. PubMed ID: 10942376
[TBL] [Abstract][Full Text] [Related]
3. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
Castro-Malaspina H
Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
[TBL] [Abstract][Full Text] [Related]
5. Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice.
Centurione L; Di Baldassarre A; Zingariello M; Bosco D; Gatta V; Rana RA; Langella V; Di Virgilio A; Vannucchi AM; Migliaccio AR
Blood; 2004 Dec; 104(12):3573-80. PubMed ID: 15292068
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1
Arciprete F; Verachi P; Martelli F; Valeri M; Balliu M; Guglielmelli P; Vannucchi AM; Migliaccio AR; Zingariello M
Exp Hematol; 2023 May; 121():30-37. PubMed ID: 36863479
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis.
Han ZC; Briere J; Nedellec G; Abgrall JF; Sensebe L; Parent D; Guern G
Eur J Haematol; 1988 Feb; 40(2):130-5. PubMed ID: 3345826
[TBL] [Abstract][Full Text] [Related]
9. Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow.
Wickenhauser C; Schmitz B; Baldus SE; Henze F; Farahmand P; Frimpong S; Thiele J; Fischer R
Leuk Res; 2000 Dec; 24(12):1013-21. PubMed ID: 11077115
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
Chagraoui H; Wendling F; Vainchenker W
Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
[TBL] [Abstract][Full Text] [Related]
11. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin-responsive essential thrombocythaemia with myelofibrosis.
Ozaki S; Kosaka M; Ozaki K; Wakatsuki S; Hashimoto T; Miyazaki H
Br J Haematol; 1997 May; 97(2):449-52. PubMed ID: 9163612
[TBL] [Abstract][Full Text] [Related]
13. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
[TBL] [Abstract][Full Text] [Related]
14. Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
Leukemia; 2017 Dec; 31(12):2709-2716. PubMed ID: 28386106
[TBL] [Abstract][Full Text] [Related]
15. Myelofibrosis: experimental models and human studies.
Taskin AL; Cohen-Solal K; Le Couedic JP; Abina MA; Villeval JL; Debili N; Casadevall N; Vainchenker W; Wendling F
Stem Cells; 1998; 16 Suppl 2():155-64. PubMed ID: 11012187
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and management of idiopathic myelofibrosis.
Reilly JT
Baillieres Clin Haematol; 1998 Dec; 11(4):751-67. PubMed ID: 10640215
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Castro-Malaspina H; Moore MA
Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
19. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
20. Emperipolesis of neutrophils by dysmorphic megakaryocytes.
Parmley RT; Kim TH; Austin RL; Alvarado CS; Ragab AH
Am J Hematol; 1982 Dec; 13(4):303-11. PubMed ID: 7158625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
